Nov 21, 2020
Beware of Long Lankin who lives in the moss
seen from China
seen from Türkiye
seen from United States
seen from Türkiye
seen from United States
seen from Malaysia
seen from Russia
seen from Türkiye
seen from United States
seen from United States
seen from Germany
seen from Türkiye
seen from Indonesia
seen from Russia
seen from United States
seen from United States
seen from Germany
seen from United States
seen from Greece
seen from Germany
Beware of Long Lankin who lives in the moss
Gilded by the Sun - Fire + Ice (Ian Read)
Ian Read, Pfizer CEO Steps Down After 8 Years
Ian Read, Pfizer CEO Steps Down After 8 Years
US drugmaker Pfizer on Monday announced that chief executive Ian Read is stepping down, handing off to chief operating officer Albert Bourla on January 1.
Read, a Scottish-American replaced Jeffrey Kindler in December 2010.
In future, the 65 year-old chemical engineer and chartered accountant will serve as executive chairman of Pfizer’s board of directors, the company said in a statement.
“It’s…
View On WordPress
Ian Read, Pfizer CEO Steps Down After 8 Years
Ian Read, Pfizer CEO Steps Down After 8 Years
Ian Read, Pfizer CEO Steps Down After 8 Years
Ian Read, Pfizer CEO Steps Down After 8 Years
US drugmaker Pfizer on Monday announced that chief executive Ian Read is stepping down, handing off to chief operating officer Albert Bourla on January 1.
Read, a Scottish-American replaced Jeffrey Kindler in December 2010.
In future, the 65 year-old chemical engineer and chartered accountant will serve as…
View On WordPress
Pfizer’s long-time CEO Ian Read to hand over reins to Albert Bourla
Pfizer’s long-time CEO Ian Read to hand over reins to Albert Bourla
There were announcements from two giant companies in different sectors about the change in their CEOs Monday morning; pharma giant Pfizer (PFE) and industrial conglomerate General Electric (GE). Pfizer announced that its long-time CEO Ian Read will be replaced by its current COO Albert Bourla from the beginning of 2019, while GE appointed Larry Culp as CEO and Chairman replacing John Flannery…
View On WordPress
fire + ice, gilded by the sun
Pfizer impulsa su liderazgo en oncología fusionándose con Medivation
Pfizer impulsa su liderazgo en oncología fusionándose con Medivation
Pfizer Inc. y Medivation Inc. anunciaron que entraron en la última etapa de negociación por la cual Pfizer adquirirá Medivation, una compañía biofarmacéutica enfocada en el desarrollo y comercialización de pequeñas moléculas para oncología por U$D 81.50 cash, sobre un total de U$D 14 billones.
“el propósito de la adquisición de Medivation es acelerar el crecimiento de los ingresos de inmediato y…
View On WordPress
